CD19x22 CAR T-cell Therapy

CD19x22 CAR T-cell therapy · University of Colorado, Denver

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19x22 CAR T-cell Therapy, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL [Phase 1]